Literature DB >> 1738025

Stereotactic radiosurgical treatment of brain metastases.

J R Adler1, R S Cox, I Kaplan, D P Martin.   

Abstract

In a series of 33 patients with reasonably controlled primary cancers, stereotactic radiosurgery was used to treat 52 brain metastases. After a mean radiological follow-up time of 5.5 months, six lesions (12%) had stabilized in size, 26 (50%) were significantly reduced, and 15 (29%) had disappeared. One large melanoma metastasis progressed relentlessly despite treatment. Five lesions (9%) had decreased in size slightly before enlarging. In two of these lesions, biopsy revealed only necrosis. In almost all cases, treatment was associated with decreased peritumoral edema. However, a group of patients with large metastases and extensive prior brain irradiation has been identified in whom prolonged symptomatic cerebral edema poses a problem. It is concluded that radiosurgery is a viable alternative to surgical resection for some cases of brain metastasis.

Entities:  

Mesh:

Year:  1992        PMID: 1738025     DOI: 10.3171/jns.1992.76.3.0444

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  43 in total

Review 1.  Radiotherapy and chemotherapy of brain metastases.

Authors:  R Soffietti; A Costanza; E Laguzzi; M Nobile; R Rudà
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

2.  Treatment of cavernous sinus tumors with linear accelerator radiosurgery.

Authors:  S D Chang; J R Doty; D P Martin; S L Hancock; J R Adler
Journal:  Skull Base Surg       Date:  1999

3.  Hypofractionated radiosurgery has a better safety profile than single fraction radiosurgery for large resected brain metastases.

Authors:  Bree R Eaton; Michael J LaRiviere; Michael J La Riviere; Sungjin Kim; Roshan S Prabhu; Kirtesh Patel; Shravan Kandula; Nelson Oyesiku; Jeffrey Olson; Walter Curran; Hui-Kuo Shu; Ian Crocker
Journal:  J Neurooncol       Date:  2015-04-11       Impact factor: 4.130

4.  Two-staged stereotactic radiosurgery for the treatment of large brain metastases: Single institution experience and review of literature.

Authors:  Elizabeth E Ginalis; Taoran Cui; Joseph Weiner; Ke Nie; Shabbar Danish
Journal:  J Radiosurg SBRT       Date:  2020

5.  Radiosurgical Treatment Verification Using Removable Megavoltage Radiation Detectors.

Authors:  Cesare H Jenkins; Robert Kahn; Georg A Weidlich; John R Adler
Journal:  Cureus       Date:  2017-11-29

6.  Radiosurgery for recurrent brain metastases after whole-brain radiotherapy : factors affecting radiation-induced neurological dysfunction.

Authors:  Ho-Shin Gwak; Hyung Jun Yoo; Sang-Min Youn; Dong Han Lee; Mi Sook Kim; Chang Hun Rhee
Journal:  J Korean Neurosurg Soc       Date:  2009-05-31

7.  Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial.

Authors:  Alexander Muacevic; Berndt Wowra; Axel Siefert; Joerg-Christian Tonn; Hans-Jakob Steiger; Friedrich W Kreth
Journal:  J Neurooncol       Date:  2007-12-22       Impact factor: 4.130

8.  Management of newly diagnosed single brain metastasis with surgical resection and permanent I-125 seeds without upfront whole brain radiotherapy.

Authors:  Michael J Petr; Christopher M McPherson; John C Breneman; Ronald E Warnick
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

Review 9.  Treatment options for brain metastases in patients with non-small-cell lung cancer.

Authors:  Sadaf Taimur; Martin J Edelman
Journal:  Curr Oncol Rep       Date:  2003-07       Impact factor: 5.075

Review 10.  The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.

Authors:  Mark E Linskey; David W Andrews; Anthony L Asher; Stuart H Burri; Douglas Kondziolka; Paula D Robinson; Mario Ammirati; Charles S Cobbs; Laurie E Gaspar; Jay S Loeffler; Michael McDermott; Minesh P Mehta; Tom Mikkelsen; Jeffrey J Olson; Nina A Paleologos; Roy A Patchell; Timothy C Ryken; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2009-12-04       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.